Navigation Links
BioMotiv Secures $21 million in Initial Funding

CLEVELAND, Sept. 5, 2012 /PRNewswire/ -- BioMotiv today announced that it has secured $21 million in financing from its founding investors, University Hospitals and the Harrington Family. 

"BioMotiv is a new model for accelerating breakthrough discoveries into medicines and aligning capital and collaborations to develop a portfolio of therapeutics," said Baiju R. Shah, Chief Executive Officer of BioMotiv.  "Through their commitment, University Hospitals and the Harrington family have once again demonstrated their dedication to solving a major national challenge that prevents promising discoveries from advancing to patient benefit."

"The challenge of translating discoveries into clinical development requires an innovative, next-generation business model," said Ron Harrington, a successful entrepreneur and recognized philanthropist. "BioMotiv's mission-aligned model and experienced team will enable it to efficiently and effectively manage a portfolio of early-stage drugs."

BioMotiv is the mission-driven, for-profit therapeutic accelerator affiliated with The Harrington Project for Discovery and Development, a $250 million initiative announced by University Hospitals this past February. "Our mission is 'To Heal. To Teach. To Discover.,'" said Achilles A. Demetriou, MD, PhD, Chief Operating Officer of University Hospitals.  "The project, supported by the generosity of the Harrington family, is a national initiative to advance the standard of care by creating structures that support physician-scientists in developing their insights into new therapies."

The initial capital will be used to launch operations and initiate the development of BioMotiv's technology portfolio which is being sourced from leading academic medical centers and industry sources from across the country.  The company plans to raise a total of $100 million in capital.

About The Harrington Project for Discovery and Development

The Harrington Project for Discovery and Development (The Harrington Project), announced in late February, is a $250 million national initiative to support the discovery and development of breakthrough discoveries by physician-scientists.  The Harrington Project, centered at University Hospitals Case Medical Center, is a new and powerful national model that addresses a set of major challenges in advancing medicine.  It includes the UH Harrington Discovery Institute, a national Innovation Support Center, and BioMotiv. The project, powered by a generous gift and investment from the Harrington family, successful entrepreneurs and recognized philanthropists in Cleveland, provides a comprehensive model to advance discoveries into development and to create novel therapies for patient care.

For more information about The Harrington Project and the UH Harrington Discovery Institute, go to:

For more information about BioMotiv, go to:

Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. BioMotiv Names New Chief Executive Officer
2. Delcath Systems, Inc. Secures $20 Million Credit Facility
3. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
4. Benvenue Medical Secures $25 Million Series D Financing
5. PLC Systems Secures Additional Financing For US Clinical Trials And General Working Capital
6. Dr. Jills Foot Pads Secures GSA Schedule and Expands to Service VA and Federal Agencies
7. Alexza Secures a $20 Million Committed Equity Financing Facility with Azimuth Opportunity, L.P.
8. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
9. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
10. Arthrosurface Hits a $100 Million Milestone
11. Vermillion Sets First Quarter 2012 Conference Call for Tuesday, May 15, 2012 at 4:30 p.m. ET
Post Your Comments:
(Date:6/26/2016)... 2016 One of Australia,s successful ... of a new biotechnology company, Noxopharm Limited [ABN 50 608 966 ... and to list on the ASX. Noxopharm is a ... enter a Phase 1 clinical study later this year. ... of the biggest problems facing cancer patients - the ability of ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
Breaking Medicine Technology:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , ... Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , ... our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from reveals that behind the tendency to set ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
Breaking Medicine News(10 mins):